IL148038A0 - Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose - Google Patents

Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose

Info

Publication number: IL148038A0
Authority: IL; Israel
Prior art keywords: ribose; carnitine; dietary supplement; energy metabolism; muscular energy
Prior art date: 2000-06-14

Application number

IL14803801A

Other languages

English (en)

Original Assignee

Sigma Tau Healthscience Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-14

Filing date

2001-06-01

Publication date

2002-09-12

2001-06-01 Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa

2002-09-12 Publication of IL148038A0 publication Critical patent/IL148038A0/xx

Links

HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 title abstract 2
PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 title abstract 2
-1 alkanoyl carnitine Chemical compound 0.000 title abstract 2
HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 title abstract 2
229960004203 carnitine Drugs 0.000 title 1
235000015872 dietary supplement Nutrition 0.000 title 1
230000037149 energy metabolism Effects 0.000 title 1
230000002708 enhancing effect Effects 0.000 title 1
230000003387 muscular Effects 0.000 title 1
239000000203 mixture Substances 0.000 abstract 2
206010002660 Anoxia Diseases 0.000 abstract 1
241000976983 Anoxia Species 0.000 abstract 1
206010021143 Hypoxia Diseases 0.000 abstract 1
206010061216 Infarction Diseases 0.000 abstract 1
206010049565 Muscle fatigue Diseases 0.000 abstract 1
UFAHZIUFPNSHSL-MRVPVSSYSA-N O-propanoyl-L-carnitine Chemical compound CCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C UFAHZIUFPNSHSL-MRVPVSSYSA-N 0.000 abstract 1
230000007953 anoxia Effects 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
IGQBPDJNUXPEMT-SNVBAGLBSA-N isovaleryl-L-carnitine Chemical compound CC(C)CC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C IGQBPDJNUXPEMT-SNVBAGLBSA-N 0.000 abstract 1
230000002107 myocardial effect Effects 0.000 abstract 1
125000002467 phosphate group Chemical class [H]OP(=O)(O[H])O[*] 0.000 abstract 1
230000037081 physical activity Effects 0.000 abstract 1
230000002035 prolonged effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
210000002027 skeletal muscle Anatomy 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
- C07H3/02—Monosaccharides
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Nutrition Science (AREA)
Food Science & Technology (AREA)
Organic Chemistry (AREA)
Polymers & Plastics (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Mycology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

IL14803801A 2000-06-14 2001-06-01 Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose IL148038A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT2000RM000323A IT1317043B1 (it)	2000-06-14	2000-06-14	Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
PCT/IT2001/000283 WO2001095915A1 (en)	2000-06-14	2001-06-01	Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose

Publications (1)

Publication Number	Publication Date
IL148038A0 true IL148038A0 (en)	2002-09-12

Family

ID=11454786

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14803801A IL148038A0 (en)	2000-06-14	2001-06-01	Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose

Country Status (19)

Country	Link
US (4)	US20030108537A1 (de)
EP (1)	EP1292312B1 (de)
AT (1)	ATE265216T1 (de)
AU (1)	AU782367B2 (de)
CA (1)	CA2381339C (de)
CZ (1)	CZ2002366A3 (de)
DE (1)	DE60103055T2 (de)
DK (1)	DK1292312T3 (de)
ES (1)	ES2219531T3 (de)
HU (1)	HU228642B1 (de)
IL (1)	IL148038A0 (de)
IT (1)	IT1317043B1 (de)
MX (1)	MXPA02001550A (de)
NO (1)	NO20020731L (de)
PL (1)	PL199641B1 (de)
PT (1)	PT1292312E (de)
SK (2)	SK287308B6 (de)
TR (1)	TR200401096T4 (de)
WO (1)	WO2001095915A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITRM20020545A1 (it) *	2002-10-30	2004-04-30	Chementecno Srl	Integratore energetico e vitaminico minerale ad azione ergogenica per la prevenzione della fatica muscolare.
GB0306394D0 (en) *	2003-03-20	2003-04-23	Univ Nottingham	Carnitine retention
WO2004112511A2 (en) *	2003-06-26	2004-12-29	Mcleod Donald M	Supplement for restoring growth hormone levels
GB0606864D0 (en) *	2006-04-05	2006-05-17	Univ Nottingham	Increades fatty acid oxidation
US8101581B2 (en) *	2007-01-23	2012-01-24	Bioenergy, Inc.	Use of D-ribose to treat cardiac arrhythmias
CN101356971B (zh) *	2007-07-30	2012-11-07	石药集团中奇制药技术（石家庄）有限公司	一种用于抗疲劳耐缺氧的保健食品组合物
JP2012500261A (ja) *	2008-08-20	2012-01-05	バイオエナジーインコーポレイティド	疲労した対象のためのｄ−リボースの使用
GB2510374A (en) *	2013-01-31	2014-08-06	Christopher Francis Bennett	Formulation comprising N-acetylcarnitine and D-ribose
GB201304112D0 (en) *	2013-03-07	2013-04-24	Univ Nottingham	Modulation of energy expenditure
BR112018007434A2 (pt)	2015-10-27	2018-10-23	Cytozyme Animal Nutrition Inc	composições para nutrição animal, usos e métodos relacionados
US10674746B2 (en)	2015-10-27	2020-06-09	Cytozyme Animal Nutrition, Inc.	Animal nutrition compositions and related methods
ITUB20155250A1 (it) *	2015-11-24	2017-05-24	Apuzzo Dario	Nuova composizione nutraceutica, somministrabile per via orale, utile per esercitare una potente stimolazione del metabolismo, in particolare del metabolismo energetico muscolare.
DE102016002090A1 (de)	2016-02-22	2017-08-24	Ribomedica S. L.	Komposition für die Nahrungsergänzung menschlicher Ernährung und deren Verwendung
WO2022215085A1 (en)	2021-04-06	2022-10-13	Celagenex Research (India) Pvt. Ltd.	A synergistic composition for potentiating stabilized atp

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE88631T1 (de) *	1986-09-17	1993-05-15	Clintec Nutrition Co	Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
US6294520B1 (en) *	1989-03-27	2001-09-25	Albert T. Naito	Material for passage through the blood-brain barrier
US5397786A (en) *	1993-01-08	1995-03-14	Simone; Charles B.	Rehydration drink
IT1291127B1 (it)	1997-04-01	1998-12-29	Sigma Tau Ind Farmaceuti	Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
US6159942A (en) *	1998-06-19	2000-12-12	Bioenergy, Inc.	Compositions for increasing energy in vivo
DE69929128T2 (de) *	1998-08-31	2006-06-29	Nipro Corp.	Nährstoffinfusionspräparat
US6579544B1 (en) *	2000-05-31	2003-06-17	Nutriex, L.L.C.	Method for supplementing the diet

2000
- 2000-06-14 IT IT2000RM000323A patent/IT1317043B1/it active
2001
- 2001-01-06 US US10/048,590 patent/US20030108537A1/en not_active Abandoned
- 2001-04-24 SK SK1729-2002A patent/SK287308B6/sk not_active IP Right Cessation
- 2001-06-01 DE DE60103055T patent/DE60103055T2/de not_active Expired - Lifetime
- 2001-06-01 EP EP01941001A patent/EP1292312B1/de not_active Expired - Lifetime
- 2001-06-01 TR TR2004/01096T patent/TR200401096T4/xx unknown
- 2001-06-01 IL IL14803801A patent/IL148038A0/xx unknown
- 2001-06-01 CA CA002381339A patent/CA2381339C/en not_active Expired - Fee Related
- 2001-06-01 HU HU0202496A patent/HU228642B1/hu not_active IP Right Cessation
- 2001-06-01 PL PL352578A patent/PL199641B1/pl unknown
- 2001-06-01 ES ES01941001T patent/ES2219531T3/es not_active Expired - Lifetime
- 2001-06-01 MX MXPA02001550A patent/MXPA02001550A/es active IP Right Grant
- 2001-06-01 WO PCT/IT2001/000283 patent/WO2001095915A1/en not_active Ceased
- 2001-06-01 DK DK01941001T patent/DK1292312T3/da active
- 2001-06-01 SK SK210-2002A patent/SK2102002A3/sk unknown
- 2001-06-01 PT PT01941001T patent/PT1292312E/pt unknown
- 2001-06-01 CZ CZ2002366A patent/CZ2002366A3/cs unknown
- 2001-06-01 AT AT01941001T patent/ATE265216T1/de active
- 2001-06-01 AU AU74487/01A patent/AU782367B2/en not_active Ceased
2002
- 2002-02-13 NO NO20020731A patent/NO20020731L/no not_active Application Discontinuation
2006
- 2006-11-27 US US11/604,390 patent/US20070116743A1/en not_active Abandoned
2010
- 2010-04-02 US US12/753,368 patent/US8518455B2/en not_active Expired - Fee Related
2013
- 2013-07-26 US US13/952,083 patent/US8747906B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2381339A1 (en)	2001-12-20
SK17292002A3 (sk)	2003-04-01
TR200401096T4 (tr)	2004-07-21
DE60103055T2 (de)	2004-10-14
DK1292312T3 (da)	2004-08-16
US8747906B2 (en)	2014-06-10
AU782367B2 (en)	2005-07-21
HU228642B1 (hu)	2013-04-29
ATE265216T1 (de)	2004-05-15
US8518455B2 (en)	2013-08-27
NO20020731D0 (no)	2002-02-13
SK287308B6 (sk)	2010-06-07
SK2102002A3 (en)	2002-05-09
MXPA02001550A (es)	2002-08-30
US20100189704A1 (en)	2010-07-29
PL352578A1 (en)	2003-08-25
AU7448701A (en)	2001-12-24
IT1317043B1 (it)	2003-05-26
EP1292312A1 (de)	2003-03-19
ITRM20000323A0 (it)	2000-06-14
HUP0202496A3 (en)	2005-02-28
PT1292312E (pt)	2004-08-31
HUP0202496A2 (hu)	2002-11-28
ES2219531T3 (es)	2004-12-01
EP1292312B1 (de)	2004-04-28
NO20020731L (no)	2002-04-11
US20070116743A1 (en)	2007-05-24
CA2381339C (en)	2009-08-11
US20030108537A1 (en)	2003-06-12
PL199641B1 (pl)	2008-10-31
CZ2002366A3 (cs)	2002-07-17
US20130309216A1 (en)	2013-11-21
ITRM20000323A1 (it)	2001-12-14
DE60103055D1 (de)	2004-06-03
WO2001095915A1 (en)	2001-12-20

Publication	Publication Date	Title
IL148038A0 (en)	2002-09-12	Dietary supplement enhancing the muscular energy metabolism, comprising an alkanoyl carnitine and ribose
CA2140768A1 (en)	1994-02-03	A Method of Increasing Creatine Supply Depot
CA2378469A1 (en)	2001-01-11	An oral solid composition comprising carbidopa, levodopa and entacapone
WO2006086667A3 (en)	2007-02-22	Antisense composition and method for treating muscle atrophy
CA2213339A1 (en)	1996-08-29	Method of treating adenosine depletion
WO1998043499A3 (en)	1999-01-07	Nutritional supplement
HUP0004439A3 (en)	2001-12-28	1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
BG103646A (en)	2000-02-29	Arylsulphonamides, their analogues and application for the treatment of neurodegenerative diseases
EP0787489A3 (de)	1997-09-10
TR200200179T2 (tr)	2002-06-21	Kas yorgunluğunun önlenmesi ve kas adaptasyonu için bileşim
BR0009765A (pt)	2002-01-02	Esteres de l-carnitina ou alcanoil l-carnitinas úteis como lipìdios catiÈnicos para a distribuição intracelular de compostos farmacologicamente ativos
CA2228281A1 (en)	1997-02-20	Use of l-carnitine and acyl l-carnitines for lowering ceramide levels
CA2253130A1 (en)	1999-05-06	A medicament for treating obesity and improving lipid metabolism
CA2386770A1 (en)	2001-04-19	Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
WO2000064426A3 (en)	2001-05-25	Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
BR9909712A (pt)	2000-12-26	Composição compreendendo l-carnitina ou um alcanoil-l-carnitina e nadh e/ou madph
MX9703810A (es)	1998-04-30	Medicamento que comprende un derivado de carnitinapara tratar la enfermedad de alzheimer en pacientes con inicio prematuro.
US8252309B2 (en)	2012-08-28	Dietary supplement energy-providing to skeletal muscles
PL367812A1 (en)	2005-03-07	Alpha-ketoglutarates of active ingredients and compositions containing same
PL322284A1 (en)	1998-01-19	Derivatives of aminoteralin useful in treating diseases of cardiovascular system
IL116747A (en)	1999-11-30	Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for the treatment of gynaecomastia
TNSN00150A1 (fr)	2005-11-10	Composition cardioactive comprenant l-carnitine et ses derives et des extraits d'aubepine (crataegus)
Silverman	1997	What are the effects of creatine supplementation on performance?
US20070117867A1 (en)	2007-05-24	Kit comprising three independent compositions and methods for building muscle, increasing strength, increasing muscle size, increasing muscle performance and reducing muscle fatigue
Oinonen	1998	Effects of 26 weeks plyometric and dynamic strength training and estrogen replacement therapy on isometric muscle strength of postmenopausal women